All ProductsDisplaying Products Alphabetically by Name (P)
| Cat. No. | 产品名称/活性 |
|---|---|
| 4485 | P 22077 |
| USP7 inhibitor | |
| 5760 | P-3FAX-Neu5Ac |
| Sialic acid analog; sialyltransferase inhibitor | |
| 6897 | P110 |
| Dynamin-related protein 1 (Drp1) inhibitor; cell-permeable | |
| 7974 | P3S |
| Reagent for modifying RNA at 2'-OH position, for SHAPE-MAP experiments | |
| 4076 | P7C3 |
| NAMPT activator; also proneurogenic and neuroprotective | |
| 6657 | PA 8 |
| PAC1 receptor antagonist | |
| 6149 | PA Janelia Fluor® 549, NHS ester |
| Yellow photoactivatable dye (Reactive group: NHS ester). Application: super resolution microscopy (SRM), single molecule tracking and live cell imaging | |
| 8815 | PA Janelia Fluor® 646, Haloalkane 最新 |
| Photoactivatable Janelia Fluor® 646 with chloroalkane handle for self-labeling tags fusion protein | |
| 6150 | PA Janelia Fluor® 646, NHS ester |
| Red photoactivatable dye (Reactive group: NHS ester). Application: super resolution microscopy (SRM), single molecule tracking and live cell imaging | |
| 6700 | PA Nic |
| Caged nicotine; photoactivated by one-photon and two-photon excitation | |
| 2581 | PAC 1 |
| Activator of procaspase-3; pro-apoptotic | |
| 1183 | PACAP 1-27 |
| Potent stimulator of adenylyl cyclase | |
| 1186 | PACAP 1-38 |
| Potent stimulator of adenylyl cyclase | |
| 3236 | PACAP 6-38 |
| Potent PAC1 receptor antagonist | |
| 5116 | PACMA 31 |
| Irreversible protein disulfide isomerase (PDI) inhibitor | |
| 2940 | PAF (C16) |
| Endogenous platelet-activating factor (PAF) | |
| 7994 | PAG 3'-fluoro-4'-piperazine |
| Functionalized cereblon ligand for PROTAC development | |
| 7996 | PAG 3'-piperazine |
| Functionalized cereblon ligand for PROTAC development | |
| 7997 | PAG 3'-piperazine-4-methylpiperidine 最新 |
| Cereblon ligand with terminal piperidine for onward chemistry | |
| 7998 | PAG 4'-piperazine |
| Functionalized cereblon ligand for PROTAC development | |
| 7999 | PAG 4'-piperazine-4-methylpiperidine |
| Cereblon ligand with terminal piperidine for onward chemistry | |
| 6551 | PAMP-12 (human, porcine) |
| Potent MRGPRX2 agonist | |
| 6552 | PAMP-20 (human) |
| MRGPRX2 agonist; also non-competitive nAChR antagonist | |
| 7410 | PARPYnD |
| PARP inhibitor; photoaffinity probe | |
| 6461 | PARPi-FL |
| Potent fluorescent PARP inhibitor; cell permeable | |
| 2562 | PB 28 dihydrochloride |
| High affinity σ2 agonist | |
| 5564 | PBS, 100 Tablets |
| PBS Tablets | |
| 5012 | PCI 29732 |
| Potent BTK inhibitor | |
| 4643 | PCI 34051 |
| Potent and selective HDAC8 inhibitor | |
| 4192 | PD 0325901 |
| Potent inhibitor of MEK1/2 | |
| 4786 | PD 0332991 isethionate |
| Potent cdk4 and cdk6 inhibitor; brain penetrant | |
| 1671 | PD 102807 |
| Selective M4 antagonist | |
| 1361 | PD 123319 ditrifluoroacetate |
| Potent and selective non-peptide AT2 antagonist | |
| 1243 | (+)-PD 128907 hydrochloride |
| High affinity D3 agonist (D3 ≥ D2 > D4) | |
| 2850 | PD 146176 |
| Selective 15-lipoxygenase inhibitor | |
| 1269 | PD 150606 |
| Cell permeable calpain inhibitor | |
| 2615 | PD 158780 |
| Potent ErbB receptor family inhibitor | |
| 3724 | PD 161570 |
| Selective FGFR inhibitor | |
| 3785 | PD 166285 dihydrochloride |
| Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1 | |
| 2520 | PD 166793 |
| Broad spectrum MMP inhibitor | |
| 1065 | PD 168077 maleate |
| High affinity, selective D4 agonist | |
| 3529 | PD 168568 dihydrochloride |
| Potent and selective D4 antagonist | |
| 3044 | PD 173074 |
| FGFR1 and -3 inhibitor | |
| 2602 | PD 176252 |
| GRP (BB2) and NMB (BB1) receptor antagonist | |
| 4237 | PD 184352 |
| Selective MEK inhibitor | |
| 2605 | PD 198306 |
| Selective inhibitor of MEK1/2 | |
| 4824 | PD 334581 |
| MEK1 inhibitor | |
| 7858 | PD 4'-oxyacetic acid |
| Functionalized cereblon ligand for PROTAC development | |
| 7859 | PD 4'-piperazine |
| Stable cereblon ligand, for PROTAC synthesis | |
| 2694 | PD 407824 |
| Potent and selective inhibitor of Chk1 and Wee1 | |
| 1363 | PD 81723 |
| Positive allosteric modulator of A1 receptors | |
| 1213 | PD 98059 |
| MEK inhibitor | |
| 0298 | L-trans-2,4-PDC |
| Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor | |
| 7007 | PDD 00017238 |
| High affinity and potent PARG inhibitor | |
| 7006 | PDD 00017272 |
| Potent PARG inhibitor | |
| 5952 | PDD 00017273 |
| Potent and selective PARG inhibitor; cell permeable | |
| 8824 | PDEδ ATTEC 12C 最新 |
| PDEδ autophagy-tethering compound (ATTEC) Degrader | |
| 7868 | PE 22-28 |
| Potent inhibitor of TREK-1 channels | |
| 5018 | PEAQX tetrasodium salt |
| Potent and GluN2A-selective NMDA antagonist | |
| 7854 | PEI STAR™ transfection reagent |
| Polyethylenimine (PEI) transfection reagent, chemically-defined | |
| 8174 | PEI STAR-Go™ transfection reagent 最新 |
| Aqueous solution of polyethylenimine (PEI) transfection reagent | |
| 6308 | PEN (mouse) |
| GPR83 agonist | |
| 4054 | PEP 005 |
| Protein kinase C activator | |
| 4239 | PF 04217903 mesylate |
| Highly selective MET inhibitor | |
| 4818 | PF 04418948 |
| Potent and selective EP2 receptor antagonist | |
| 5915 | PF 04449613 |
| Potent PDE9 inhibitor; brain penetrant | |
| 6538 | PF 04449913 maleate |
| Potent Smo antagonist | |
| 6374 | PF 04457845 |
| Potent and selective irreversible FAAH inhibitor | |
| 5755 | PF 04479745 |
| Potent and selective 5-HT2C agonist | |
| 5863 | PF 04620110 |
| Potent and selective DGAT-1 inhibitor; orally bioavailable | |
| 6347 | PF 04628935 |
| Potent ghrelin receptor inverse agonist | |
| 6024 | PF 04671536 hydrochloride |
| Potent and selective PDE8B/8A inhibitor | |
| 4916 | PF 04885614 |
| Potent and selective NaV1.8 channel blocker; active in vivo | |
| 5931 | PF 05089771 |
| Potent and selective Nav1.7 channel blocker | |
| 5790 | PF 05175157 |
| Potent acetyl-CoA carboxylase (ACC) 1 and 2 inhibitor | |
| 6405 | PF 05180999 |
| Potent and selective PDE2A inhibitor | |
| 6350 | PF 05190457 |
| High affinity and selective ghrelin receptor inverse agonist | |
| 5752 | PF 06260933 dihydrochloride |
| MAP4K4 (HGK) inhibitor; also inhibits MINK and TNIK | |
| 6115 | PF 06273340 |
| Potent and selective pan-Trk inhibitor; peripherally restricted | |
| 6004 | PF 06281355 |
| Selective myeloperoxidase (MPO) inhibitor | |
| 6114 | PF 06409577 |
| Potent and selective allosteric activator of AMPK | |
| 6348 | PF 06424439 |
| Potent and selective DGAT2 inhibitor | |
| 4710 | PF 06465469 |
| Potent ITK inhibitor; also inhibits BTK | |
| 6506 | PF 06551600 malonate |
| Potent and selective JAK3 inhibitor | |
| 6169 | PF 06726304 acetate |
| Highly potent and SAM-competitive EZH2 inhibitor | |
| 4238 | PF 184 |
| Potent and selective IKKβ inhibitor | |
| 5751 | PF 3084014 hydrobromide |
| Potent γ-secretase inhibitor | |
| 4279 | PF 3644022 |
| Potent MK2 inhibitor | |
| 6005 | PF 3758309 dihydrochloride |
| Potent PAK4 inhibitor; orally available | |
| 4175 | PF 3845 |
| Selective FAAH inhibitor | |
| 3354 | PF 429242 dihydrochloride |
| Competitive inhibitor of SREBP site 1 protease | |
| 4278 | PF 431396 |
| Dual FAK/PYK2 inhibitor | |
| 4032 | PF 4708671 |
| S6K1 inhibitor | |
| 4277 | PF 477736 |
| Selective Chk1 inhibitor | |
| 4281 | PF 4800567 hydrochloride |
| Selective casein kinase 1ε inhibitor | |
| 6346 | PF 5006739 |
| Potent CK1δ/ε inhibitor | |
| 5262 | PF 5274857 hydrochloride |
| High affinity and selective Smoothened (Smo) receptor antagonist | |
| 3239 | PF 573228 |
| Potent and selective FAK inhibitor | |
| 3316 | PF 670462 |
| Potent and selective CK1ε and CK1δ inhibitor | |
| 3291 | PF 915275 |
| Potent and selective 11β-hydroxysteroid dehydrogenase inhibitor | |
| 4445 | PFI 1 |
| BET bromodomain inhibitor | |
| 4892 | (R)-PFI 2 hydrochloride |
| Potent and selective SETD7 inhibitor | |
| 5400 | (S)-PFI 2 hydrochloride |
| Negative control of (R)-PFI 2 hydrochloride (Cat. No. 4892) | |
| 5072 | PFI 3 |
| Potent and selective SMARCA2/4 and polybromo 1 inhibitor | |
| 7963 | PFI 653 |
| Potent and selective vanin 1 inhibitor | |
| 5339 | PFK 15 |
| Selective PFKFB3 inhibitor | |
| 3887 | PG 01037 dihydrochloride |
| Selective D3 antagonist | |
| 5866 | PH 797804 |
| Potent and selective p38α/β inhibitor | |
| 3092 | PHA 543613 hydrochloride |
| Potent and selective α7 nAChR agonist | |
| 3134 | PHA 568487 |
| Selective α7 nAChR agonist | |
| 2693 | PHA 665752 |
| Potent and selective MET inhibitor | |
| 3140 | PHA 767491 hydrochloride |
| Cdk inhibitor; potently inhibits cdk9; also inhibits MK2 | |
| 1027 | PHCCC |
| Potent group I mGlu antagonist | |
| 6771 | PHPS1 sodium salt |
| Shp2 (PTPN11) inhibitor | |
| 2662 | PHTPP |
| Selective ERβ antagonist | |
| 2930 | PI 103 hydrochloride |
| Inhibitor of PI 3-kinase, mTOR and DNA-PK | |
| 2814 | PI 828 |
| PI 3-kinase inhibitor, more potent than LY 294002 (Cat. No. 1130) | |
| 7902 | PIK 90 |
| Potent PI3K inhibitor, also used in hPSCs mesendoderm differentiation | |
| 3255 | PJ 34 hydrochloride |
| Potent PARP inhibitor | |
| 5338 | PK-THPP |
| Potent K2P9.1 (TASK-3) channel blocker | |
| 1904 | PKA inhibitor fragment (6-22) amide |
| Potent protein kinase A inhibitor | |
| 6221 | PKI (5-24) |
| High affinity PKA inhibitor | |
| 2546 | PKI 14-22 amide, myristoylated |
| Cell-permeable protein kinase A inhibitor | |
| 4941 | PKI 166 hydrochloride |
| Potent EGFR-kinase inhibitor | |
| 6238 | PKRA 7 |
| Potent prokineticin (PK) 1 and 2 receptor antagonist; antitumor; BBB penetrant | |
| 6580 | PKUMDL WQ 2101 |
| Negative allosteric modulator of 3-phosphoglycerate dehydrogenase (PHGDH) | |
| 6581 | PKUMDL WQ 2201 |
| Negative allosteric modulator of 3-Phosphoglycerate dehydrogenase (PHGDH) | |
| 2567 | PLP (139-151) |
| Encephalitogenic myelin proteolipid fragment | |
| 7505 | PLpro inhibitor 19 |
| SARS-CoV-2 PLpro and replication inhibitor | |
| 7357 | PLpro inhibitor 6 |
| SARS-CoV and SARS-CoV-2 PLpro inhibitor | |
| 1380 | PMPA (NAALADase inhibitor) |
| GCP II inhibitor | |
| 4486 | PMSF |
| Non-selective protease inhibitor; also blocks anandamide metabolism | |
| 5196 | PMX 205 |
| Potent C5a receptor peptide antagonist | |
| 5473 | PMX 53 |
| Potent C5a receptor antagonist | |
| 5697 | PMX 53c |
| Negative control for PMX 53 (Cat. No. 5473) | |
| 6891 | PND 1186 |
| Potent FAK inhibitor; orally bioavailable | |
| 2498 | PNU 120596 |
| Positive allosteric modulator of α7 nAChRs; active in vivo | |
| 1985 | PNU 142633 |
| Highly selective 5-HT1D agonist | |
| 2303 | PNU 282987 |
| Selective α7 nAChR agonist | |
| 2095 | PNU 37883 hydrochloride |
| Vascular Kir6 (KATP) channel blocker | |
| 3534 | PNU 74654 |
| β-catenin binder; inhibits Wnt signaling | |
| 2689 | POM 1 |
| Inhibitor of E-NTPDases | |
| 1397 | PP 1 |
| Potent, selective Src family kinase inhibitor | |
| 3894 | PP 121 |
| Dual kinase inhibitor; inhibits PI 3-K family kinases | |
| 1407 | PP 2 |
| Potent, selective Src family kinase inhibitor | |
| 4257 | PP 242 |
| Dual mTORC1/mTORC2 inhibitor | |
| 2794 | PP 3 |
| Negative control for PP 2 (Cat. No. 1407) | |
| 6515 | (D)-PPA 1 |
| PD-1/PD-L1 interaction inhibitor | |
| 0625 | PPADS tetrasodium salt |
| Non-selective P2 antagonist | |
| 0683 | iso-PPADS tetrasodium salt |
| Non-selective P2X antagonist | |
| 0620 | 4-PPBP maleate |
| Specific σ ligand, NMDA antagonist | |
| 3870 | (±)-PPCC oxalate |
| Selective sigma (σ) agonist (σ1> σ2) | |
| 2530 | PPDA |
| GluN2C/GluN2D-selective NMDA antagonist | |
| 1034 | 4-P-PDOT |
| MT2 antagonist | |
| 1426 | PPT |
| Subtype-selective ERα agonist | |
| 4862 | PPTN hydrochloride |
| High affinity and selective P2Y14 antagonist | |
| 4730 | PPY A |
| Potent inhibitor of Abl T315l mutant and wild-type Abl kinases | |
| 2768 | PQ 401 |
| IGF1R inhibitor | |
| 4482 | PR 619 |
| Broad spectrum DUB inhibitor | |
| 0589 | PRE-084 hydrochloride |
| Highly selective σ1 agonist | |
| 3710 | PRIMA-1MET |
| Restores mutant p53 activity | |
| 8004 | PROTAC®(H-PGDS)-7 |
| Potent hematopoietic prostaglandin D2 synthase Degrader (PROTAC®) | |
| 8005 | PROTAC®(H-PGDS)-8 |
| Negative control for PROTAC®(H-PGDS)-7 (Cat. No. 8004) | |
| 5047 | PRT 4165 |
| Inhibitor of Bmi1/Ring1A; blocks histone H2A ubiquitination | |
| 6748 | PRX 07034 |
| Potent and selective 5-HT6 antagonist | |
| 2573 | PSB 069 |
| Non-selective NTPDase inhibitor | |
| 3983 | PSB 0739 |
| Highly potent P2Y12 antagonist | |
| 4334 | PSB 0777 ammonium salt |
| Potent adenosine A2A agonist | |
| 3199 | PSB 0788 |
| Selective A2B antagonist | |
| 2010 | PSB 10 hydrochloride |
| Potent, highly selective hA3 receptor antagonist/inverse agonist | |
| 4333 | PSB 1114 |
| Potent, selective P2Y2 agonist | |
| 2009 | PSB 1115 |
| Selective human A2B antagonist; water-soluble | |
| 6083 | PSB 12379 |
| Ecto-5'-nucleotidase (CD73) inhibitor | |
| 3198 | PSB 603 |
| Highly selective A2B antagonist | |
| 6372 | PSB CB5 |
| Selective GPR18 antagonist | |
| 4042 | PSC 833 |
| Inhibitor of P-gp-mediated MDR | |
| 6425 | PSEM 308 hydrochloride |
| PSAML141F-GlyR and PSAML141F,Y115F-5-HT3 chimeric ion channel agonist | |
| 6426 | PSEM 89S |
| PSAML141F-GlyR and PSAML141F,Y115F-5-HT3 chimeric ion channel agonist | |
| 5321 | PSNCBAM-1 |
| Negative allosteric modulator of CB1 receptors | |
| 7651 | PT-65 |
| Potent GSK3 Degrader (PROTAC®) | |
| 2954 | PX 12 |
| Thioredoxin-1 inhibitor | |
| 2978 | PYR 41 |
| Ubiquitin-activating enzyme (E1) inhibitor | |
| 7876 | PZ 3022 |
| PanK Activator | |
| 7218 | PZM21 |
| Selective μ receptor agonist | |
| 4493 | Paliperidone |
| 5-HT2A antagonist; also D2 antagonist; atypical antipsychotic | |
| 0879 | Palmitoylethanolamide |
| Selective GPR55 agonist. FAAH and PAA substrate | |
| 7038 | Palonosetron hydrochloride |
| Highly potent and high affinity 5-HT3 antagonist | |
| 4637 | Pam2CSK4 |
| TLR2/6 agonist; induces TNF-α production | |
| 4633 | Pam3CSK4 |
| TLR1/2 agonist; induces cytokine production | |
| 1154 | Pancreatic Polypeptide (human) |
| NPY Y4 agonist; involved in gastrointestinal tract function | |
| 7629 | Panobinostat |
| Pan-histone deacetylase inhibitor | |
| 6301 | Parathyroid hormone (1-34) (rat) |
| Parathyroid hormone (PTH) receptor agonist | |
| 3011 | Parathyroid hormone (1-34) (human) |
| Parathyroid hormone (PTH) receptor agonist | |
| 2141 | Paroxetine maleate |
| Highly potent and selective 5-HT uptake inhibitor | |
| 2006 | Paxilline |
| SERCA ATPase blocker. Also potent BKCa channel blocker | |
| 6349 | Pelitinib |
| Potent and irreversible EGFR inhibitor; orally bioavailable | |
| 6185 | Pemetrexed |
| Thymidylate synthetase inhibitor, also inhibits dihydrofolate reductase, GARFT and AICART | |
| 4617 | Penitrem A |
| Potent and selective KCa1.1 (BK) channel blocker | |
| 2033 | Pentostatin |
| Adenosine deaminase inhibitor | |
| 2687 | Pentylenetetrazole |
| CNS stimulant | |
| 6423 | Pep 2-8 |
| Potent PCSK9 inhibitor | |
| 1190 | Pepstatin A |
| Selective and high affinity cathepsin D inhibitor | |
| 7314 | Pepstatin A Janelia Fluor® 526 |
| Fluorogenic green-emitting lysosome tracker and stain | |
| 1618 | Peptide YY (3-36) |
| Selective NPY Y2 receptor agonist | |
| 5166 | Perhexiline maleate |
| Carnitine palmitoyltransferase 1 and 2 (CPT1/2) inhibitor | |
| 6087 | Perifosine |
| PKB/Akt inhibitor; also modulates Kv2.1 current | |
| 5549 | Perlapine |
| Potent hM3Dq and hM4Di DREADD agonist in vitro | |
| 4944 | Peroxy Orange 1 |
| Fluorescent hydrogen peroxide indicator | |
| 3097 | Pertussis Toxin |
| Catalyzes ADP-ribosylation of Gi, Go and Gt | |
| 6451 | Pexacerfont |
| Potent and selective CRF1 antagonist; anxiolytic | |
| 7590 | Pexidartinib |
| Potent CSF-1R inhibitor | |
| 7392 | 5-Ph-IAA |
| Selective and potent TAG Degrader for auxin-inducible degron 2 system | |
| 4535 | Phalloidin |
| Promotes actin polymerization | |
| 5782 | Phalloidin-FITC |
| Green-fluorescent cytoskeleton stain. Binds and labels F-actin. Used for: F-actin staining. Application: fluorescent microscopy, immunofluorescence (IHC, ICC) | |
| 7201 | Phalloidin-Janelia Fluor® 646 |
| Red-fluorescent F-actin probe. Binds and labels F-actin. Used for: F-actin labelling. Application: confocal microscopy, super resolution microscopy (SRM) including dSTORM & STED, flow cytometry | |
| 5783 | Phalloidin-TRITC |
| Red-orange fluorescent cytoskeleton stain. Binds and labels F-actin. Used for: F-actin staining. Application: fluorescent microscopy, immunofluorescence (IHC, ICC) | |
| 7873 | Phen Green SK diacetate |
| Heavy metal ion indicator, membrane permeable | |
| 3379 | Phenamil |
| Inhibits TRPP3-mediated currents; also inhibits epithelial Na+ channels | |
| 2557 | Phencyclidine hydrochloride |
| Non-competitive NMDA antagonist | |
| 6431 | Phentolamine Mesylate |
| Adrenergic α receptor antagonist; antihypertensive | |
| 7729 | Phenyl-glutarimide 4'-piperazine |
| Piperazine-functionalized cereblon ligand for PROTAC development | |
| 7670 | Phenyl-glutarimide 4'-oxyacetic acid |
| Functionalized cereblon ligand for PROTAC development | |
| 2682 | Sodium 4-Phenylbutyrate |
| Histone deacetylase inhibitor | |
| 2838 | (R)-(-)-Phenylephrine hydrochloride |
| α1 agonist | |
| 0680 | 2-Phenylmelatonin |
| Potent melatonin agonist | |
| 4153 | Phorbol 12,13-dibutyrate |
| Protein kinase C activator | |
| 1201 | Phorbol 12-myristate 13-acetate |
| Protein kinase C activator | |
| 4995 | Phortress |
| Prodrug of the antitumor agent 5F 203 | |
| 5778 | 2-Phospho-L-ascorbic acid trisodium salt |
| Ascorbic acid derivative; maintains differentiation potential in bone marrow-derived MSCs | |
| 4325 | Phosphocreatine disodium salt |
| Phosphate reservoir | |
| 6333 | Phosphoramidon disodium salt |
| Neutral endopeptidase and endothelin converting enzyme inhibitor | |
| 7328 | Photo-lenalidomide-acid |
| Functionalized photoswitchable cereblon ligand for Degraders | |
| 7362 | Phototrexate |
| Photoswitchable inhibitor of human dihydrofolate reductase | |
| 4914 | Phrixotoxin 3 |
| Potent blocker of NaV1.2, NaV1.3 and NaV1.5 channels | |
| 0622 | Physostigmine hemisulfate |
| Cholinesterase inhibitor | |
| 1554 | Piceatannol |
| Inhibits TNF-induced NF-κB activation | |
| 4525 | Piclamilast |
| Potent and selective PDE4 inhibitor | |
| 2956 | Picropodophyllotoxin |
| Selective IGF1R inhibitor | |
| 1128 | Picrotoxin |
| GABAA antagonist | |
| 1267 | Pifithrin-α hydrobromide |
| p53 inhibitor. Also aryl hydrocarbon receptor agonist | |
| 3843 | Cyclic Pifithrin-α hydrobromide |
| p53 inhibitor | |
| 2653 | Pifithrin-μ |
| Inhibitor of p53-mitochondrial binding | |
| 0694 | Pilocarpine hydrochloride |
| Muscarinic agonist | |
| 7667 | Pimavanserin |
| Selective 5-HT2A inverse agonist | |
| 6182 | Pimonidazole |
| Hypoxia detection reagent | |
| 0937 | Pimozide |
| D2-like antagonist; also high affinity 5-HT7 antagonist | |
| 4124 | Pioglitazone hydrochloride |
| Selective PPARγ agonist; antidiabetic agent | |
| 1093 | Pirfenidone |
| Antifibrotic agent; regulates cytokine levels in vivo | |
| 4942 | Pitavastatin calcium |
| HMG-CoA reductase inhibitor | |
| 6070 | Pladienolide B |
| mRNA splicing inhibitor; antitumor | |
| 4847 | PluriSln 1 |
| SCD-1 inhibitor | |
| 4287 | Poly(I:C) |
| TLR3 agonist | |
| 7739 | Polyamine Supplement x1000 (lyophilized) |
| Media supplement to boost cell growth; used as component of CEPT cocktail to enhance stem cell viability | |
| 7711 | Polybrene |
| Viral transduction enhancer | |
| 3197 | Polygodial |
| TRPA1 channel activator; analgesic and antifungal | |
| 6302 | Pomalidomide |
| Cereblon binder; also TNF-α inhibitor and antiangiogenic | |
| 7094 | Pomalidomide 4'-PEG1-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 7203 | Pomalidomide 4'-PEG1-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7434 | Pomalidomide 4'-PEG1-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7212 | Pomalidomide 4'-PEG2-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 6637 | Pomalidomide 4'-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7307 | Pomalidomide 4'-PEG2-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 6681 | Pomalidomide 4'-PEG3-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 7204 | Pomalidomide 4'-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7435 | Pomalidomide 4'-PEG3-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7213 | Pomalidomide 4'-PEG4-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 6963 | Pomalidomide 4'-PEG4-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7436 | Pomalidomide 4'-PEG4-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7095 | Pomalidomide 4'-PEG5-acid |
| Cereblon ligand with PEG linker and terminal acid for onward chemistry | |
| 7924 | Pomalidomide 4'-PEG5-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7437 | Pomalidomide 4'-PEG5-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7732 | Pomalidomide 4'-alkylC10-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6851 | Pomalidomide 4'-alkylC2-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7439 | Pomalidomide 4'-alkylC2-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7096 | Pomalidomide 4'-alkylC3-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7205 | Pomalidomide 4'-alkylC3-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7440 | Pomalidomide 4'-alkylC3-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7209 | Pomalidomide 4'-alkylC4-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7441 | Pomalidomide 4'-alkylC4-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 6682 | Pomalidomide 4'-alkylC5-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 6716 | Pomalidomide 4'-alkylC5-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7442 | Pomalidomide 4'-alkylC5-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7210 | Pomalidomide 4'-alkylC6-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7923 | Pomalidomide 4'-alkylC6-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7443 | Pomalidomide 4'-alkylC6-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7097 | Pomalidomide 4'-alkylC7-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 7208 | Pomalidomide 4'-alkylC7-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7211 | Pomalidomide 4'-alkylC8-acid |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | |
| 6944 | Pomalidomide 4'-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 7470 | Pomalidomide 5'-fluoro-6'-piperazine |
| Cereblon ligand with terminal piperazine for onward chemistry | |
| 7471 | Pomalidomide 5'-fluoro-6'-piperazine-4-methylpiperidine |
| Cereblon ligand with terminal piperidine for onward chemistry | |
| 7468 | Pomalidomide 5'-piperazine |
| Cereblon ligand with terminal piperazine for onward chemistry | |
| 7469 | Pomalidomide 5'-piperazine-4-methylpiperidine |
| Cereblon ligand with terminal piperidine for onward chemistry | |
| 7913 | Pomalidomide 5'-piperidine-acid |
| Cereblon ligand with piperidine linker and terminal acid for onward chemistry | |
| 5225 | Ponceau S Staining Solution |
| Stain used to detect protein bands after Western blotting | |
| 4174 | Pramipexole dihydrochloride |
| Selective D3 agonist | |
| 5031 | Pramlintide |
| Synthetic version of amylin (Cat. No. 3418) | |
| 6317 | Prasugrel |
| Irreversible P2Y12 antagonist; antiplatelet and orally active | |
| 2318 | Pravastatin sodium salt |
| HMG-CoA reductase inhibitor | |
| 0623 | Prazosin hydrochloride |
| α1 and α2B antagonist; also MT3 antagonist | |
| 3652 | Pregnanolone |
| Postitive allosteric modulator of GABAA receptors | |
| 5376 | Pregnenolone sulfate sodium salt |
| NMDA potentiator; also GABAA inhibitor and TRPM3 activator | |
| 7630 | Pridopidine |
| Highly selective σ1 agonist | |
| 7321 | Pritelivir |
| Potent and selective herpes simplex virus (HSV) helicase primase inhibitor | |
| 7361 | ProK |
| Unnatural amino acid, propargyl lysine derivative | |
| 4023 | ProTx II |
| Selective NaV1.7 channel blocker | |
| 4107 | Probenecid |
| MRP and OAT3 inhibitor | |
| 1102 | Procaterol hydrochloride |
| Potent β2 agonist | |
| 2835 | Progesterone |
| Endogenous progesterone receptor agonist | |
| 1478 | Proglumide sodium salt |
| Non-selective CCK antagonist; orally active | |
| 5135 | Propidium iodide |
| Red-fluorescent DNA stain, membrane impermeant to live cells. Used for: apoptosis detection, nuclear counterstaining, viability staining. Application: flow cytometry, confocal microscopy, fluorescence microscopy | |
| 0624 | Propranolol hydrochloride |
| β antagonist | |
| 0835 | (R)-(+)-Propranolol hydrochloride |
| β antagonist. Less active enantiomer of propranolol (Cat. No. 0624) | |
| 0834 | (S)-(-)-Propranolol hydrochloride |
| β antagonist. More active enantiomer of propranolol (Cat. No. 0624) | |
| 5151 | Prosaptide TX14(A) |
| Potent GPR37 and GPR37L1 agonist | |
| 2296 | Prostaglandin E2 |
| Promotes HSCs expansion; increases HSCs engraftment; also endogenous prostaglandin | |
| 4214 | Prostaglandin F2α |
| Naturally-occurring prostanoid; potent vasoconstrictor | |
| 5500 | Protease Inhibitor Cocktail I |
| Protease inhibitor cocktail for mammalian cells | |
| 8098 | ProtiFect STAR™ Protein Transfection Reagent |
| Protein transfection reagent | |
| 5042 | Psalmotoxin 1 |
| Potent and selective ASIC1a channel blocker | |
| 4367 | Psora 4 |
| Potent KV1.3 channel blocker | |
| 6862 | Psoralen-triethylene glycol azide |
| RNA conformation probe; reagent for COMRADES RNA platform | |
| 3384 | (Z)-Pugnac |
| O-GlcNAcase and β-hexosaminidase inhibitor | |
| 4551 | Purmorphamine |
| Smo receptor agonist | |
| 4089 | Puromycin dihydrochloride |
| Protein synthesis inhibitor | |
| 1580 | Purvalanol A |
| Cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 | |
| 1581 | Purvalanol B |
| Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5 | |
| 6941 | Pyr 10 |
| Selective TRPC3 inhibitor | |
| 3751 | Pyr3 |
| Selective TRPC3 inhibitor | |
| 6577 | Pyridone 6 |
| Potent pan-JAK inhibitor; induces intermediate mesoderm; cell-permeable | |
| 4763 | Pyridostatin pentahydrochloride |
| Stabilizes G-quadruplexes; induces DNA damage and cell cycle arrest | |
| 2478 | 2-Pyridylethylamine dihydrochloride |
| H1 agonist | |
| 3918 | Pyrimethamine |
| Potent inhibitor of multidrug and toxin extrusion (MATE) transporters; also DHFR and STAT3 inhibitor | |
| 4978 | Pyrintegrin |
| Enhances survival of human ESCs following enzymatic dissociation |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800